London, UK, Research Triangle Park, NC & Santa Clara, CA -- GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™(gabapentin A Co

read more>>

CAMBRIDGE, Mass. & STOCKHOLM -- Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum (STO: BVT) today announced that they have restructured the collaboration agreement for the companies' long-acting, recombinant Factor VIII Fc fusion protein (rFVIIIFc) in hemophilia A patients and the Under

read more>>

STOCKHOLM -- The European Medicines Agency (EMEA) recommends orphan drug status for Aprea's treatment of acute myeloid leukemia (AMLThe treatment is currently undergoing a Phase I clinical study and a final decision from the European Commission regarding status is expected in a few weeks. Aprea is

read more>>

ANN ARBOR, Mich. -- Elderly people with visual disorders that are left untreated are significantly more likely to develop Alzheimer's disease -- the most common form of dementia, according to a University of Michigan Health System studyThe study used Medicare data and shows that those with poor vi

read more>>

The drug avosentan substantially reduces urinary protein loss in people with type 2 diabetes and kidney disease, but the drug causes serious side effects, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASNThe results suggest that lower doses

read more>>

ST. PAUL, Minn. -- New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010The research

read more>>

ROCKVILLE, MD -- EntreMed, Inc. (Nasdaq: ENMD), today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company’s lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AMLThe FDA accepted EntreMed’s a

read more>>

Lyon (France), Philadelphia (USA -- ERYtech Pharma, a specialty pharma company located in France and in USA (Philadelphia), is pleased to announce a collaborative research agreement in the field of personalized medicine focusing on ERYtech’s flagship product, GRASPA®, which consists of P

read more>>

Ninewells Hospital in Dundee has become the first national clinical centre in Scotland for treating patients with a very rare skin disorder that leaves them extremely vulnerable to sunlightOnly about ten patients in Scotland are affected by xeroderma pigmentosum - a condition first identified in t

read more>>

MIGDAL HAEMEK, Israel -- Neurodegenerative diseases such as Alzheimer's set a challenge for modern medicine, as their origins are unclear and the comprehension of the progression of symptoms often relies upon a patients' behaviorApplied Spectral Imaging (ASI) a leading provider of comprehensive im

read more>>